How big is the Cancer Biopsies Market?

The Cancer Biopsies Market size is expected to reach USD 29.93 billion in 2024 and grow at a CAGR of 11.46% to reach USD 51.48 billion by 2029. Read More

What is the current Cancer Biopsies Market size?

In 2024, the Cancer Biopsies Market size is expected to reach USD 29.93 billion. Read More

Who are the key players in Cancer Biopsies Market?

Illumina, Inc., Becton, Dickinson and Company, Myriad Genetics, Thermo Fisher Scientific and QIAGEN are the major companies operating in the Cancer Biopsies Market. Read More

Which is the fastest growing region in Cancer Biopsies Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Cancer Biopsies Market?

In 2024, the North America accounts for the largest market share in Cancer Biopsies Market. Read More

What years does this Cancer Biopsies Market cover, and what was the market size in 2023?

In 2023, the Cancer Biopsies Market size was estimated at USD 26.85 billion. The report covers the Cancer Biopsies Market historical market size for years: . The report also forecasts the Cancer Biopsies Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Cancer Biopsies Market Share

Statistics for the 2023 & 2024 Cancer Biopsies market share, created by Mordor Intelligence™ Industry Reports. Cancer Biopsies share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Cancer Biopsies Industry

The cancer biopsies market is moderately competitive. In terms of market share, few of the major players currently dominate the market. With the rising patient awareness levels and high prevalence of cancer diseases, many regional players are expected to be a part of the cancer biopsies market over the forecast period. Some of the major players in the market are QIAGEN NV, Illumina Inc., Becton, Dickinson and Company, Myriad Genetics, and Thermo Fisher Scientific.